Prudential Financial Inc Mustang Bio, Inc. Transaction History

Prudential Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.66 - $2.64 $18,014 - $28,649	-10,852 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $5,023 - $6,541	-1,947 Reduced 15.21%	10,852 $29,000
Q2 2021 Aug 16, 2021	BUY	$2.7 - $3.81 $34,557 - $48,764	12,799 New	12,799 $42,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.